QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Laspia, M F Articles by Mathews, M B Search for Related Content PubMed PubMed Citation Articles by Laspia, M F Articles by Mathews, M B Social Bookmarking                   What's this?

Research Papers

Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation.

Cold Spring Harbor Laboratory, New York 11724.

Abstract

We studied the combined effects of Tat and general trans-activators, such as E1A and phorbol esters, on human immunodeficiency virus-1 (HIV-1) gene expression. Interaction between these two types of trans-activators may be involved in the transition from transcriptional quiesence during viral latency to active gene expression during productive infection. E1A cooperated with Tat to produce a fourfold greater increase in accumulation of full-length, cytoplasmic HIV-1-directed RNA than is expected if they were acting additively to increase RNA accumulation. Similarly, phorbol 12-myristate 13-acetate (PMA) also cooperated with Tat to elevate HIV RNA levels synergistically. Analysis of transcription rates across the HIV-1-directed transcription unit indicated, unexpectedly, that synergy between Tat and E1A could not be accounted for by increased promoter proximal transcription rates that were merely additive. However, Tat and E1A produced a greater than additive increase in transcription rates in the 3' end of the gene. These findings imply that synergy between Tat and E1A (or other general transcriptional activators) is due principally to stabilization of transcriptional elongation. Furthermore, the observation that Tat elicits only a small increase in promoter proximal transcription in the presence of E1A suggests that the magnitude of the effect of Tat on initiation is decreased when the basal level of transcription is increased. These findings underscore the importance of the ability of Tat to stabilize elongation, as well as to stimulate initiation, in an HIV-1-directed transcription unit.

CiteULike

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				C. Mischiati, G. Feriotto, M. Borgatti, P. Giacomini, and R. Gambari Characterization of a Major Histocompatibility Complex Class II X-Box-Binding Protein Enhancing Tat-Induced Transcription Directed by the Human Immunodeficiency Virus Type 1 Long Terminal Repeat J. Virol., October 1, 2000; 74(19): 8989 - 9001. [Abstract] [Full Text]

				M. Zhou, M. A. Halanski, M. F. Radonovich, F. Kashanchi, J. Peng, D. H. Price, and J. N. Brady Tat Modifies the Activity of CDK9 To Phosphorylate Serine 5 of the RNA Polymerase II Carboxyl-Terminal Domain during Human Immunodeficiency Virus Type 1 Transcription Mol. Cell. Biol., July 15, 2000; 20(14): 5077 - 5086. [Abstract] [Full Text]

				Y. Ramanathan, S. M. Reza, T. M. Young, M. B. Mathews, and T. Pe'ery Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate J. Virol., July 1, 1999; 73(7): 5448 - 5458. [Abstract] [Full Text]

				A. M. Trubetskoy, S. A. Okenquist, and J. Lenz R Region Sequences in the Long Terminal Repeat of a Murine Retrovirus Specifically Increase Expression of Unspliced RNAs J. Virol., April 1, 1999; 73(4): 3477 - 3483. [Abstract] [Full Text]

				L. Cupelli, S. A. Okenquist, A. Trubetskoy, and J. Lenz The Secondary Structure of the R Region of a Murine Leukemia Virus Is Important for Stimulation of Long Terminal Repeat-Driven Gene Expression J. Virol., October 1, 1998; 72(10): 7807 - 7814. [Abstract] [Full Text] [PDF]

				Y. Zhu, T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro Genes & Dev., October 15, 1997; 11(20): 2622 - 2632. [Abstract] [Full Text] [PDF]

				H. S.Y. Mancebo, G. Lee, J. Flygare, J. Tomassini, P. Luu, Y. Zhu, J. Peng, C. Blau, D. Hazuda, D. Price, et al. P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro Genes & Dev., October 15, 1997; 11(20): 2633 - 2644. [Abstract] [Full Text] [PDF]

				L. F. Garcia-Martinez, D. Ivanov, and R. B. Gaynor Association of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes J. Biol. Chem., March 14, 1997; 272(11): 6951 - 6958. [Abstract] [Full Text] [PDF]

				L S Tiley, S J Madore, M H Malim, and B R Cullen The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes & Dev., November 1, 1992; 6(11): 2077 - 2087. [Abstract] [PDF]

				H Kato, H Sumimoto, P Pognonec, C H Chen, C A Rosen, and R G Roeder HIV-1 Tat acts as a processivity factor in vitro in conjunction with cellular elongation factors. Genes & Dev., April 1, 1992; 6(4): 655 - 666. [Abstract] [PDF]

				C D Southgate and M R Green The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes & Dev., December 1, 1991; 5(12b): 2496 - 2507. [Abstract] [PDF]